Edition:
United States

People: Biogen Inc (BIIB.O)

BIIB.O on Nasdaq

297.19USD
2 Dec 2016
Change (% chg)

$1.41 (+0.48%)
Prev Close
$295.78
Open
$296.53
Day's High
$299.95
Day's Low
$293.04
Volume
1,429,360
Avg. Vol
1,626,213
52-wk High
$333.65
52-wk Low
$223.02

Holtzman, Steven 

Mr. Steven H. Holtzman is Executive Vice President - Corporate Development of Biogen Inc., since January 2011. Mr. Holtzman has served as our Executive Vice President, Corporate Development since January 2011. Prior to that, Mr. Holtzman was a founder of Infinity Pharmaceuticals, Inc., a drug discovery and development company, where he served as Chair of the Board of Directors from company inception in 2001 to November 2012, Executive Chair of the Board of Directors in 2010 and as Chief Executive Officer from 2001 to December 2009. From 1994 to 2001, Mr. Holtzman was Chief Business Officer at Millennium Pharmaceuticals Inc., a biopharmaceutical company. From 1986 to 1994, he was a founder, member of the Board of Directors and Executive Vice President of DNX Corporation, a biotechnology company. From 1996 to 2001, Mr. Holtzman served as presidential appointee to the national Bioethics Advisory Commission. He received his B.A in Michigan State University and B.Phil. graduate degree, which he attended as a Rhodes Scholar in Oxford University.

Basic Compensation

Total Annual Compensation, USD 1,318,960
Restricted Stock Awards, USD 1,988,880
Long-Term Incentive Plans, USD --
All Other, USD 35,780
Fiscal Year Total, USD 3,343,620

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --